[{"NetIncomeLoss_1_Q2_USD":-10353000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":49258449.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_2_Q2_USD":-0.67,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q2_USD":-0.21,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestIncomeOther_2_Q2_USD":149000.0,"InterestIncomeOther_1_Q2_USD":107000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":2550000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-33000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-224740000.0,"Depreciation_2_Q2_USD":130000.0,"Depreciation_1_Q2_USD":51000.0,"AssetsCurrent_0_Q2_USD":302969000.0,"OperatingLeaseExpense_2_Q2_USD":44000.0,"OperatingLeaseExpense_1_Q2_USD":22000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":24995136.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7649179.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":5000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-33000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":21000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":25540922.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2599000.0,"ConversionOfStockSharesIssued1_2_Q2_shares":1.0,"ResearchAndDevelopmentExpense_2_Q2_USD":13221000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7861000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":200000000.0,"CommonStockValue_0_Q2_USD":5000.0,"OtherNonoperatingIncome_2_Q2_USD":149000.0,"OtherNonoperatingIncome_1_Q2_USD":107000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":198000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":186054000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":687000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":124000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":7200000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-17201000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-10332000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1627000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":50404000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":1415000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4096000.0,"CommonStockSharesIssued_0_Q2_shares":49261995.0,"Assets_0_Q2_USD":303493000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":21000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":138000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-51315000.0,"MarketableSecurities_0_Q2_USD":248747000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-54512000.0,"CommonStockSharesOutstanding_0_Q2_shares":49261995.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":231802000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":560000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-15826000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":135100000.0,"LiabilitiesCurrent_0_Q2_USD":6739000.0,"AccountsPayableCurrent_0_Q2_USD":2816000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3818000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":30000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":243000.0,"AdditionalPaidInCapital_0_Q2_USD":348097000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":524000.0,"NetIncomeLoss_2_Q2_USD":-17168000.0,"StockholdersEquity_0_Q2_USD":296754000.0,"ProfitLoss_2_Q2_USD":-17168000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.21,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.67,"ShareBasedCompensation_2_Q2_USD":983000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3011000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-17317000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":13000.0,"OperatingIncomeLoss_1_Q2_USD":-10460000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":303493000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1373000.0,"PreferredStockSharesAuthorized_0_Q2_shares":200000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":983000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":687000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1084000.0,"OperatingExpenses_2_Q2_USD":17317000.0,"OperatingExpenses_1_Q2_USD":10460000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":186148000.0,"ConversionOfStockAmountConverted1_2_Q2_USD":160214000.0,"Ticker":"EWTX","CIK":"1710072","name":"EDGEWISE THERAPEUTICS, INC.","OfficialName":"Edgewise Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"388173759.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]